Baricitinib Exhibits Sustained Effectiveness in Severe Alopecia Areata: Study Shows
Saudi Arabia: Researchers have found in a 52-week real-world cohort that baricitinib showed sustained effectiveness and good tolerability in patients with severe alopecia areata. The results, published in Acta Dermatovenerologica…